Jessica Grossman, MD is the CEO of Medicines360. She has a proven track record of leading successful women’s health organizations.
As a medical technology executive, she brings a wealth of experience in both product development and commercialization and the ability to accelerate profitable, mission-driven business models.
Prior to joining Medicines360, Dr. Grossman served as President and Founding CEO of Sense4Baby, Inc. Dr. Grossman was also Founder and President of Gynesonics, an early-stage medical device company focused on minimally invasive solutions for fibroid tumors. Under her leadership, the organization developed the first intrauterine ultrasound-guided radiofrequency ablation device for fibroid tumors. She has also been a Medical Director at Ethicon Endo-Surgery, part of the Johnson and Johnson family of companies.
Dr. Grossman holds numerous patents and has published several peer-reviewed articles.
She earned her MD at Thomas Jefferson University and her undergraduate degree with honors from Brandeis University.